Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

October 31, 2018 16:05 ET | Source: Unity Biotechnology, Inc.

UNITY Biotechnology, Inc. to Announce Third Quarter 2018 Financial Results

SAN FRANCISCO, Oct. 31, 2018 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (“UNITY”) (NASDAQ:UBX), a biotechnology company developing therapeutics to extend healthspan by slowing, halting or...
September 24, 2018 16:05 ET | Source: Unity Biotechnology, Inc.

UNITY Biotechnology, Inc. to Participate in the Cantor Fitzgerald Annual Global Healthcare Conference

SAN FRANCISCO, Sept. 24, 2018 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (“UNITY”) (NASDAQ:UBX), a biotechnology company developing therapeutics to extend healthspan by slowing, halting or...
September 05, 2018 16:05 ET | Source: Unity Biotechnology, Inc.

UNITY Biotechnology, Inc. to Participate in the Morgan Stanley 16th Annual Global Healthcare Conference

SAN FRANCISCO, Sept. 05, 2018 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (“UNITY”) (NASDAQ:UBX), a biotechnology company developing therapeutics to extend healthspan by slowing, halting or...
August 09, 2018 16:05 ET | Source: Unity Biotechnology, Inc.

UNITY Biotechnology, Inc. Reports Second Quarter 2018 Financial Results

SAN FRANCISCO, Aug. 09, 2018 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (“UNITY”) (NASDAQ:UBX), a biotechnology company developing therapeutics to extend healthspan by slowing, halting or...
July 31, 2018 16:05 ET | Source: Unity Biotechnology, Inc.

UNITY Biotechnology, Inc. to Announce Second Quarter 2018 Financial Results

SAN FRANCISCO, Calif., July 31, 2018 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (“UNITY”) (NASDAQ:UBX), a biotechnology company developing therapeutics to extend healthspan by slowing, halting or...
June 25, 2018 08:00 ET | Source: Unity Biotechnology, Inc.

UNITY Biotechnology, Inc. Announces First Patient Treated in UBX0101 Phase 1 Trial for Osteoarthritis of the Knee

SAN FRANCISCO, June 25, 2018 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (“UNITY”) (NASDAQ:UBX), a biotechnology company developing therapeutics to extend healthspan by slowing, halting or...
June 13, 2018 16:00 ET | Source: Unity Biotechnology, Inc.

UNITY Biotechnology, Inc. Added to Russell 3000®, 2000® and MicroCap® Indexes

SAN FRANCISCO, June 13, 2018 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (“UNITY”) (NASDAQ:UBX), a biotechnology company developing therapeutics to extend healthspan by slowing, halting or...
June 07, 2018 17:00 ET | Source: Unity Biotechnology, Inc.

UNITY Biotechnology, Inc. Reports First Quarter 2018 Financial Results

SAN FRANCISCO, June 07, 2018 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (“UNITY”) (NASDAQ:UBX), a biotechnology company developing therapeutics to extend healthspan by slowing, halting or...
June 05, 2018 16:05 ET | Source: Unity Biotechnology, Inc.

UNITY Biotechnology, Inc. to Participate in the Goldman Sachs 39th Annual Global Healthcare Conference

SAN FRANCISCO, June 05, 2018 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (“UNITY”) (NASDAQ:UBX), a biotechnology company developing therapeutics to extend healthspan by slowing, halting or...
May 29, 2018 16:05 ET | Source: Unity Biotechnology, Inc.

UNITY Biotechnology, Inc. to Announce First Quarter 2018 Financial Results

SAN FRANCISCO, May 29, 2018 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (“UNITY”) (NASDAQ:UBX), a biotechnology company developing therapeutics to extend healthspan by slowing, halting or...